Fig. 2From: Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012Orphan designations at time of application, described by stage of development. *Indicates significant differences at the 0.05 levelBack to article page